$AURA
Aura Biosciences, Inc.

2022 Q3 Form 10-Q Financial Statement

#000095017022016911 Filed on August 11, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.762M $4.306M $4.535M
YoY Change 88.22% 10.1%
% of Gross Profit
Research & Development $11.29M $9.510M $8.276M
YoY Change 77.42% 43.4% 97.75%
% of Gross Profit
Depreciation & Amortization $300.0K $300.0K $300.0K
YoY Change 50.0% 50.0% 50.0%
% of Gross Profit
Operating Expenses $11.29M $9.510M $8.276M
YoY Change 77.42% 43.4% 97.75%
Operating Profit -$16.06M -$13.82M -$12.81M
YoY Change 80.49% 56.98% 116.15%
Interest Expense $474.0K $353.0K -$19.00K
YoY Change 731.58% -835.42%
% of Operating Profit
Other Income/Expense, Net $154.0K $348.0K -$24.00K
YoY Change 170.18% -782.35%
Pretax Income -$15.90M -$13.47M -$12.84M
YoY Change 79.92% -8.87%
Income Tax
% Of Pretax Income
Net Earnings -$15.90M -$13.47M -$12.84M
YoY Change 79.92% 52.15% 116.55%
Net Earnings / Revenue
Basic Earnings Per Share -$0.54 -$0.46 -$0.44
Diluted Earnings Per Share -$0.54 -$0.46 -$439.3K
COMMON SHARES
Basic Shares Outstanding 29.27M 29.25M 29.22M
Diluted Shares Outstanding 29.27M 29.25M 29.21M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $111.5M $122.1M $133.3M
YoY Change 36.28% 32.47%
Cash & Equivalents $61.11M $53.85M $108.4M
Short-Term Investments $50.41M $68.28M $24.90M
Other Short-Term Assets $306.0K $261.0K $131.0K
YoY Change 456.36% -61.5%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $115.9M $127.7M $139.6M
YoY Change 38.88% 37.46%
LONG-TERM ASSETS
Property, Plant & Equipment $5.475M $5.803M $5.911M
YoY Change 23.26% 9.12%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $768.0K $893.0K $125.0K
YoY Change -55.04% 94.13%
Total Long-Term Assets $27.24M $7.352M $6.840M
YoY Change 275.92% 27.24%
TOTAL ASSETS
Total Short-Term Assets $115.9M $127.7M $139.6M
Total Long-Term Assets $27.24M $7.352M $6.840M
Total Assets $143.1M $135.0M $146.4M
YoY Change 57.82% 36.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.724M $1.198M $1.956M
YoY Change -0.69% -50.43%
Accrued Expenses $7.779M $4.114M $2.805M
YoY Change 131.52% 61.59%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $9.964M $5.812M $5.003M
YoY Change 70.88% 9.33%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $18.13M $118.0K $333.0K
YoY Change 3004.28% -84.95%
Total Long-Term Liabilities $18.13M $118.0K $333.0K
YoY Change 3004.28% -84.95%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.964M $5.812M $5.003M
Total Long-Term Liabilities $18.13M $118.0K $333.0K
Total Liabilities $28.09M $5.930M $5.336M
YoY Change 337.93% -2.79%
SHAREHOLDERS EQUITY
Retained Earnings -$194.3M -$178.4M -$165.0M
YoY Change 38.29%
Common Stock $0.00 $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $115.1M $129.1M $141.1M
YoY Change
Total Liabilities & Shareholders Equity $143.1M $135.0M $146.4M
YoY Change 57.82% 36.86%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$15.90M -$13.47M -$12.84M
YoY Change 79.92% 52.15% 116.55%
Depreciation, Depletion And Amortization $300.0K $300.0K $300.0K
YoY Change 50.0% 50.0% 50.0%
Cash From Operating Activities -$10.76M -$10.63M -$15.20M
YoY Change 23.82% -8.65% 195.89%
INVESTING ACTIVITIES
Capital Expenditures -$63.00K -$74.00K $599.0K
YoY Change -89.01% -89.9% 743.66%
Acquisitions
YoY Change
Other Investing Activities $18.01M -$43.37M -$24.90M
YoY Change
Cash From Investing Activities $17.95M -$43.44M -$25.50M
YoY Change -3231.94% 5826.47% 35812.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 104.0K 309.0K 17.00K
YoY Change -109.32% -99.65% -99.98%
NET CHANGE
Cash From Operating Activities -10.76M -10.63M -15.20M
Cash From Investing Activities 17.95M -43.44M -25.50M
Cash From Financing Activities 104.0K 309.0K 17.00K
Net Change In Cash 7.290M -53.76M -40.68M
YoY Change -170.24% -171.81% -149.44%
FREE CASH FLOW
Cash From Operating Activities -$10.76M -$10.63M -$15.20M
Capital Expenditures -$63.00K -$74.00K $599.0K
Free Cash Flow -$10.70M -$10.55M -$15.80M
YoY Change 31.79% -3.18% 203.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.072993
dei City Area Code
CityAreaCode
617
dei Local Phone Number
LocalPhoneNumber
500-8864
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
dei Amendment Flag
AmendmentFlag
false
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001501796
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40971
dei Entity Registrant Name
EntityRegistrantName
AURA BIOSCIENCES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
32-0271970
dei Entity Address Address Line1
EntityAddressAddressLine1
80 Guest Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Boston
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02135
dei Security12b Title
Security12bTitle
Common Stock, par value $0.00001 per share
dei Trading Symbol
TradingSymbol
AURA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
dei Entity Bankruptcy Proceedings Reporting Current
EntityBankruptcyProceedingsReportingCurrent
true
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
29273647
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53849000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
149063000
CY2022Q2 us-gaap Marketable Securities
MarketableSecurities
68282000
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
28000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
23000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5510000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4618000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
127669000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
153704000
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
893000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
125000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
656000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
950000
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
3000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-16000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5803000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5251000
CY2022Q2 us-gaap Assets
Assets
135021000
CY2021Q4 us-gaap Assets
Assets
160030000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1198000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2401000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
633000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
615000
CY2022Q2 aura Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
3981000
CY2021Q4 aura Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
4256000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5812000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7272000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
51000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
360000
CY2022Q2 aura Warrant Liability Noncurrent
WarrantLiabilityNoncurrent
67000
CY2021Q4 aura Warrant Liability Noncurrent
WarrantLiabilityNoncurrent
83000
CY2022Q2 us-gaap Liabilities
Liabilities
5930000
CY2021Q4 us-gaap Liabilities
Liabilities
7715000
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29266848
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29266848
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29211643
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29211643
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
307659000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
304452000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-178440000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-152137000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-128000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
129091000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
152315000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
135021000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
160030000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9510000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6632000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17786000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10817000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4306000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2169000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8841000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3911000
CY2022Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
13816000
CY2021Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
8801000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
26627000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
14728000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-13816000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-8801000
us-gaap Operating Income Loss
OperatingIncomeLoss
-26627000
us-gaap Operating Income Loss
OperatingIncomeLoss
-14728000
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-61000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-51000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
324000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-51000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-13468000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-8852000
us-gaap Net Income Loss
NetIncomeLoss
-26303000
us-gaap Net Income Loss
NetIncomeLoss
-14779000
CY2022Q2 aura Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-13468000
CY2021Q2 aura Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
52000
aura Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
52000
CY2022Q2 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
292000
CY2021Q2 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
4000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
319000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
3000
CY2022Q2 us-gaap Other Expenses
OtherExpenses
5000
CY2021Q2 us-gaap Other Expenses
OtherExpenses
0
us-gaap Other Expenses
OtherExpenses
11000
us-gaap Other Expenses
OtherExpenses
3000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
348000
CY2021Q2 aura Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-12480000
aura Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-26303000
aura Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-20738000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-28.53
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-28.53
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.90
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.90
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-49.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-49.49
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29251480
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29251480
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
437464
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
437464
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29232661
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29232661
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
419059
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
419059
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-13468000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-8852000
us-gaap Net Income Loss
NetIncomeLoss
-26303000
us-gaap Net Income Loss
NetIncomeLoss
-14779000
CY2022Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-123000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-128000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-123000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-128000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13591000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
17000
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-5000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8852000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26431000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-12835000
CY2022Q1 us-gaap Shares Outstanding
SharesOutstanding
29217236
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
141086000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1594000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14779000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-108713000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
185000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
265000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5927000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-114190000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
271000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
20000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-8852000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-122751000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
152315000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1287000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
309000
CY2022Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-123000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-13468000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
129091000
us-gaap Profit Loss
ProfitLoss
-26303000
us-gaap Profit Loss
ProfitLoss
-14779000
us-gaap Depreciation
Depreciation
552000
us-gaap Depreciation
Depreciation
385000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-16000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1000
aura Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
52000
us-gaap Share Based Compensation
ShareBasedCompensation
2881000
us-gaap Share Based Compensation
ShareBasedCompensation
456000
aura Marketable Securities Accretion
MarketableSecuritiesAccretion
-143000
aura Other Operating Activities
OtherOperatingActivities
-4000
aura Other Operating Activities
OtherOperatingActivities
-1000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
892000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-396000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1515000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1612000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-388000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
246000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25828000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11634000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
673000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
733000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
71266000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
3000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-68939000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-733000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
326000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
285000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
280000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
326000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
87233000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-94441000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
74866000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
149211000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17487000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
54770000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
92353000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
426000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
152000
aura Initial Measurement Of Right Of Use Assets And Lease Liabilities For Operating Lease
InitialMeasurementOfRightOfUseAssetsAndLeaseLiabilitiesForOperatingLease
536000
aura Remeasurement Of Right Of Use Assets And Lease Liabilities For Lease Modification
RemeasurementOfRightOfUseAssetsAndLeaseLiabilitiesForLeaseModification
390000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
516000
aura Deferred Offering Costs In Accounts Payable
DeferredOfferingCostsInAccountsPayable
55000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53849000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
92197000
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
28000
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
31000
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
893000
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
125000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54770000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
92353000
CY2021Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On October 22, 2021, the Company effected a reverse stock split of the Company’s common stock on a 1-for-13.7 basis, or the Reverse Stock Split.
us-gaap Net Income Loss
NetIncomeLoss
-26300000
us-gaap Net Income Loss
NetIncomeLoss
-14800000
CY2022Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
122100000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-178400000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4618000
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
261000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5251000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
66000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5510000
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9091000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8015000
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3288000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2764000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5803000
CY2022Q2 us-gaap Depreciation
Depreciation
300000
CY2021Q2 us-gaap Depreciation
Depreciation
200000
us-gaap Depreciation
Depreciation
600000
us-gaap Depreciation
Depreciation
400000
CY2022Q2 us-gaap Prepaid Insurance
PrepaidInsurance
1083000
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
2734000
CY2022Q2 aura Prepaid Research And Development Expenses
PrepaidResearchAndDevelopmentExpenses
4118000
CY2021Q4 aura Prepaid Research And Development Expenses
PrepaidResearchAndDevelopmentExpenses
1754000
CY2022Q2 aura Prepaid License Agreements
PrepaidLicenseAgreements
48000
CY2021Q4 aura Prepaid License Agreements
PrepaidLicenseAgreements
64000
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
128000
CY2022Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
68282000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2022Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
68410000
CY2022Q2 aura Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
1594000
CY2021Q4 aura Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
1686000
CY2022Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
1887000
CY2021Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2147000
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
500000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
423000
CY2022Q2 aura Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
3981000
CY2021Q4 aura Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
4256000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29266848
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29266848
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29211643
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29211643
CY2021Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
10000000
CY2021Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.00001
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
11.56
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.56
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1200000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
500000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
600000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
10000.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0253
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0107
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0309
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0107
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3D
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M2D
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7544
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7437
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7685
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7443
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
161000
CY2021Q2 us-gaap Variable Lease Cost
VariableLeaseCost
76000
us-gaap Variable Lease Cost
VariableLeaseCost
337000
us-gaap Variable Lease Cost
VariableLeaseCost
142000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1287000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
271000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2881000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
456000
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
14900000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M13D
CY2021Q1 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
4516
CY2021Q1 aura Lease Commencement Date
LeaseCommencementDate
2021-05-01
CY2021Q1 aura Additional Area Of Rented Space
AdditionalAreaOfRentedSpace
1000
CY2021Q1 aura Additional Leased Space Commencement Date
AdditionalLeasedSpaceCommencementDate
2021-06-15
CY2021Q1 aura Operating Lease Termination Date
OperatingLeaseTerminationDate
2023-07-31
CY2021Q1 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2021Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P12M
CY2021Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
3000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
11000
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
155000
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
129000
us-gaap Operating Lease Cost
OperatingLeaseCost
309000
us-gaap Operating Lease Cost
OperatingLeaseCost
216000
CY2022Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
2000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
4000
CY2022Q2 us-gaap Lease Cost
LeaseCost
318000
CY2021Q2 us-gaap Lease Cost
LeaseCost
208000
us-gaap Lease Cost
LeaseCost
650000
us-gaap Lease Cost
LeaseCost
369000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
15000
us-gaap Operating Lease Payments
OperatingLeasePayments
305000
us-gaap Operating Lease Payments
OperatingLeasePayments
214000
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y29D
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y29D
CY2021Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0794
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0351
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0351
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
319000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
377000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
696000
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
12000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
684000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
633000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
51000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-13468000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-8852000
us-gaap Net Income Loss
NetIncomeLoss
-26303000
us-gaap Net Income Loss
NetIncomeLoss
-14779000
CY2021Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3628000
us-gaap Dividends Preferred Stock
DividendsPreferredStock
5959000
CY2022Q2 aura Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-13468000
CY2021Q2 aura Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-12480000
aura Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-26303000
aura Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-20738000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29251480
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29251480
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
437464
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
437464
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29232661
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29232661
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
419059
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
419059
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-28.53
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-28.53
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.90
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.90
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-49.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-49.49
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4354831
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25471827
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0

Files In Submission

Name View Source Status
0000950170-22-016911-index-headers.html Edgar Link pending
0000950170-22-016911-index.html Edgar Link pending
0000950170-22-016911.txt Edgar Link pending
0000950170-22-016911-xbrl.zip Edgar Link pending
aura-20220630.htm Edgar Link pending
aura-20220630.xsd Edgar Link pending
aura-ex10_1.htm Edgar Link pending
aura-ex31_1.htm Edgar Link pending
aura-ex31_2.htm Edgar Link pending
aura-ex32_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img110370785_0.jpg Edgar Link pending
img110370785_1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
aura-20220630_lab.xml Edgar Link unprocessable
aura-20220630_pre.xml Edgar Link unprocessable
aura-20220630_def.xml Edgar Link unprocessable
aura-20220630_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
aura-20220630_cal.xml Edgar Link unprocessable